Edition:
United Kingdom

People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

66.35USD
22 Aug 2019
Change (% chg)

$-0.72 (-1.07%)
Prev Close
$67.07
Open
$67.28
Day's High
$67.43
Day's Low
$66.21
Volume
62,329
Avg. Vol
50,972
52-wk High
$86.67
52-wk Low
$39.83

Marken, James 

Mr. James G. Marken is Senior Vice President, Operations and Product Development of the Company, since may 2016. He had served as ANIP’s Vice President, Operations and Product Development, since March 2009. He has served as the Company’s Vice President, Operations, since June 2013 and was promoted to Senior Vice President, Operations and Product Development in May 2016. Mr. Marken joined ANIP in March 2007 as General Manager of the Minnesota facilities. As Senior Vice President, Operations and Product Development, Mr. Marken has been principally responsible for the following areas: manufacturing, packaging, engineering/maintenance, purchasing, warehousing and product development. Mr. Marken brings over 30 years of pharmaceutical industry experience to the Company. Prior to joining ANIP in March 2007, he worked for Solvay Pharmaceuticals as plant manager and in various departments including quality control, validation and manufacturing. Mr. Marken holds a B.S. degree in Chemistry from Bemidji State University.

Basic Compensation

Total Annual Compensation, USD 579,695
Restricted Stock Award, USD 251,064
Long-Term Incentive Plans, USD --
All Other, USD 178,830
Fiscal Year Total, USD 1,009,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Brown

273,573

Arthur Przybyl

4,197,930

Stephen Carey

1,438,750

Robert Schrepfer

1,444,160

James Marken

1,009,590

Thomas Haughey

252,569
As Of  31 Dec 2018